Data Composite

Rifampin Injection Shortage

2 of 3 tracked records currently active across 3 manufacturers.

Manufacturers report shortage status per product/package to the FDA independently, so the same generic drug can be short from one company while another still has supply -- the table below breaks that down company by company.

CompanyBrand nameStatusLast updated
Fresenius Kabi USA, LLC RIFAMPIN Current 07/21/2026
Mylan Institutional, a Viatris Company RIFAMPIN Current 07/17/2026
Sanofi-Aventis U.S. LLC RIFADIN IV To Be Discontinued 04/20/2026

← All shortages